全球醫用食品市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球特殊醫學用途食品市場預計將從2025年的290.1億美元成長至2034年的468.1億美元，2026年至2034年的複合年成長率（CAGR）為5.46%。該市場正經歷顯著成長，主要得益於人們對疾病特異性營養管理和預防醫學的認知不斷提高。特殊醫學用途食品是專門配製以滿足慢性病和代謝紊亂患者營養需求的食品。糖尿病、癌症、胃腸道疾病和神經系統疾病盛行率的上升是推動市場需求的重要因素。此外，人們對個人化營養管理和臨床膳食管理的日益關注也促進了全球特殊醫學用途食品產業的擴張。

人口老化和醫療保健成本不斷上漲是推動市場成長的主要因素。醫療保健專業人員擴大推薦治療性食品作為輔助性治療，以改善患者的康復和整體健康。消費者對功能性營養產品的偏好日益成長，以及食品科學和技術的進步，進一步促進了產品創新。此外，監管支持以及患者和看護者對治療性營養的認知不斷提高，也有助於全球市場的滲透。

營養科學和個人化醫療解決方案領域的持續研究確保了非常積極的市場前景。居家醫療服務和數位健康平台的擴展有望改善人們獲得專業營養產品的途徑。此外，製造商正在投資研發創新配方和植物來源醫用食品，以滿足不斷變化的消費者偏好。隨著預防醫學和疾病管理的重要性日益凸顯，預計未來幾年市場將保持持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球醫用食品市場：依產品分類

• 市場分析、洞察與預測
• 粉末
• 藥片
• 液體
• 軟膠囊
• 其他產品

第5章 全球醫用食品市場：依應用領域分類

• 市場分析、洞察與預測
• 糖尿病神經病變
• 癌症相關惡病質
• ADHD
• 阿茲海默症
• 代謝性疾病
• 胃腸道疾病
• 慢性腎臟病
• 其他用途

第6章 全球醫用食品市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 腸內營養

第7章 全球醫用食品市場：依病患小組

• 市場分析、洞察與預測
• 兒童
• 成人
• 老年人

第8章 全球醫用食品市場：依分銷管道分類

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

第9章 全球醫用食品市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • Nestle Health Science
  • Danone Nutricia
  • Fresenius Kabi AG
  • Reckitt Benckiser Group Plc（Mead Johnson Nutrition）
  • FrieslandCampina
  • Baxter International Inc
  • B. Braun SE
  • Meiji Holdings Co.Ltd
  • Balchem Corporation
  • Morinaga Milk Industry Co.Ltd
  • Ajinomoto CambrookeInc
  • MetagenicsInc
  • Primus PharmaceuticalsInc
  • Vitaflo International Ltd

The global medical foods market size is expected to reach USD 46.81 Billion in 2034 from USD 29.01 Billion in 2025, growing at a CAGR of 5.46 during 2026-2034.This market is witnessing considerable growth due to rising awareness regarding disease-specific nutritional management and preventive healthcare. Medical foods are specially formulated products designed to meet the nutritional requirements of patients suffering from chronic diseases and metabolic disorders. Increasing prevalence of diabetes, cancer, gastrointestinal diseases, and neurological disorders is significantly driving market demand. Growing emphasis on personalized nutrition and clinical dietary management is also supporting the expansion of the medical foods industry worldwide.

Increasing aging populations and healthcare expenditure are key factors accelerating market growth. Healthcare professionals are increasingly recommending medical foods as supportive therapies to improve patient recovery and overall health outcomes. Rising consumer preference for functional nutrition products and advancements in food science technologies are further boosting product innovation. In addition, favorable regulatory support and increasing awareness about therapeutic nutrition among patients and caregivers are contributing to greater market adoption globally.

Future prospects for the market remain highly favorable due to continuous research in nutritional science and personalized healthcare solutions. Expansion of home healthcare services and digital health platforms is expected to improve accessibility to specialized nutritional products. Manufacturers are also investing in innovative formulations and plant-based medical foods to address changing consumer preferences. As preventive healthcare and disease management continue gaining importance, the market is projected to witness sustained growth in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Powder
• Pills / Tablets
• Liquid
• Soft-Gel Capsules
• Other Products

By Application

• Diabetic Neuropathy
• Cancer-Related Cachexia
• ADHD
• Alzheimer's Disease
• Metabolic Disorders
• Gastro-Intestinal Disorders
• Chronic Kidney Disease
• Other Applications

By Route Of Administration

• Oral
• Enteral

By Patient Group

• Pediatric
• Adult
• Geriatric

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

COMPANIES PROFILED

• Abbott Laboratories, Nestle Health Science, Danone Nutricia, Fresenius Kabi AG, Reckitt Benckiser Group plc (Mead Johnson Nutrition), FrieslandCampina, Baxter International Inc., B. Braun SE, Meiji Holdings Co., Ltd., Balchem Corporation, Morinaga Milk Industry Co., Ltd., Ajinomoto Cambrooke, Inc., Metagenics, Inc., Primus Pharmaceuticals, Inc., Vitaflo International Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL FOODS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pills / Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Soft-Gel Capsules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICAL FOODS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diabetic Neuropathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cancer-Related Cachexia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. ADHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Alzheimer's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Metabolic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Gastro-Intestinal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Chronic Kidney Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICAL FOODS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Enteral Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICAL FOODS MARKET: BY PATIENT GROUP 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Patient Group
• 7.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Geriatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MEDICAL FOODS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Hospital Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Retail Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Online Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MEDICAL FOODS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Application
  • 9.2.3 By Route Of Administration
  • 9.2.4 By Patient Group
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Application
  • 9.3.3 By Route Of Administration
  • 9.3.4 By Patient Group
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Application
  • 9.4.3 By Route Of Administration
  • 9.4.4 By Patient Group
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Application
  • 9.5.3 By Route Of Administration
  • 9.5.4 By Patient Group
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Application
  • 9.6.3 By Route Of Administration
  • 9.6.4 By Patient Group
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL MEDICAL FOODS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 Nestle Health Science
  • 11.2.3 Danone Nutricia
  • 11.2.4 Fresenius Kabi AG
  • 11.2.5 Reckitt Benckiser Group Plc (Mead Johnson Nutrition)
  • 11.2.6 FrieslandCampina
  • 11.2.7 Baxter International Inc
  • 11.2.8 B. Braun SE
  • 11.2.9 Meiji Holdings Co.Ltd
  • 11.2.10 Balchem Corporation
  • 11.2.11 Morinaga Milk Industry Co.Ltd
  • 11.2.12 Ajinomoto CambrookeInc
  • 11.2.13 MetagenicsInc
  • 11.2.14 Primus PharmaceuticalsInc
  • 11.2.15 Vitaflo International Ltd